Erratum: Coformulation of doxorubicin and curcumin in poly-(d, l -lactide- co -glycolide) nanoparticles suppresses the development of multidrug resistance in k562 cells (Molecular Pharmaceutics (2011) 8:3 (852-866) DOI: 10.1021/mp100455h);Coformulation of doxorubicin and curcumin in poly(d, l -lactide-co- glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells

Molecular Pharmaceutics

Volumn 8, Issue 3, 2011, Pages 852-866

  Misra, Ranjita ^a   Sahoo, Sanjeeb K ^a  

^a INSTITUTE OF LIFE SCIENCES   (India)

Author keywords

BCL 2; bcr abl; curcumin; Doxorubicin; dual drug loaded NPs; K562 cells; nuclear efflux

Indexed keywords

BCR ABL PROTEIN; CURCUMIN; DOXORUBICIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; NANOPARTICLE; POLYGLACTIN; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN K 562; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG FORMULATION; DRUG RETENTION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MULTIDRUG RESISTANCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROFLUOROMETRY; WESTERN BLOTTING;

EID: 79958271282     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400618m     Document Type: Erratum

References (51)

1. Czyz, M.; Jakubowska, J.; Sztiller-Sikorska, M. STI571/doxorubicin concentration-dependent switch for diverse caspase actions in CML cell line K562 Biochem. Pharmacol. 2008, 75, 1761-1773
2. Laroche-Clary, A.; Larrue, A.; Robert, J. Down-regulation of bcr-abl and bcl-x(L) expression in a leukemia cell line and its doxorubicin-resistant variant by topoisomerase II inhibitors Biochem. Pharmacol. 2000, 60, 1823-1828
3. Wang, X.; Song, Y.; Ren, J.; Qu, X. Knocking-down cyclin A(2) by siRNA suppresses apoptosis and switches differentiation pathways in K562 cells upon administration with doxorubicin PLoS One 2009, 4, e6665
4. Xiong, X. B.; Ma, Z.; Lai, R.; Lavasanifar, A. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin Biomaterials 2010, 31, 757-768
5. Fan, L.; Li, F.; Zhang, H.; Wang, Y.; Cheng, C.; Li, X.; Gu, C. H.; Yang, Q.; Wu, H.; Zhang, S. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance Biomaterials 2010, 31, 5634-5642
6. Rajagopal, A.; Simon, S. M. Subcellular localization and activity of multidrug resistance proteins Mol. Biol. Cell 2003, 14, 3389-3399 (Pubitemid 37013135)
7. Chen, V. Y.; Posada, M. M.; Blazer, L. L.; Zhao, T.; Rosania, G. R. The role of the VPS4A-exosome pathway in the intrinsic egress route of a DNA-binding anticancer drug Pharm. Res. 2006, 23, 1687-1695 (Pubitemid 44200530)
8. Chen, V. Y.; Posada, M. M.; Zhao, L.; Rosania, G. R. Rapid doxorubicin efflux from the nucleus of drug-resistant cancer cells following extracellular drug clearance Pharm. Res. 2007, 24, 2156-2167 (Pubitemid 47493579)
9. Zhang, K. Z.; Xu, J. H.; Huang, X. W.; Wu, L. X.; Su, Y.; Chen, Y. Z. Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells Acta Pharmacol. Sin. 2007, 28, 105-110 (Pubitemid 46046633)
10. Hui, R. C.; Francis, R. E.; Guest, S. K.; Costa, J. R.; Gomes, A. R.; Myatt, S. S.; Brosens, J. J.; Lam, E. W. Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells Mol. Cancer Ther. 2008, 7, 670-678 (Pubitemid 351482149)
11. Pakunlu, R. I.; Cook, T. J.; Minko, T. Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin Pharm. Res. 2003, 20, 351-359 (Pubitemid 36288363)
12. Bill, M. A.; Bakan, C.; Benson, D. M., Jr.; Fuchs, J.; Young, G.; Lesinski, G. B. Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines Mol. Cancer Ther. 2009, 8, 2726-2735
13. Sa, G.; Das, T. Anti cancer effects of curcumin: cycle of life and death Cell Div. 2008, 3, 14
14. Reuter, S.; Charlet, J.; Juncker, T.; Teiten, M. H.; Dicato, M.; Diederich, M. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells Ann. N.Y. Acad. Sci. 2009, 1171, 436-447
15. Anuchapreeda, S.; Leechanachai, P.; Smith, M. M.; Ambudkar, S. V.; Limtrakul, P. N. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells Biochem. Pharmacol. 2002, 64, 573-582
16. Ganta, S.; Amiji, M. Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells Mol. Pharmaceutics 2009, 6, 928-939
17. Romiti, N.; Tongiani, R.; Cervelli, F.; Chieli, E. Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes Life Sci. 1998, 62, 2349-2358 (Pubitemid 28273164)
18. Wu, L. X.; Xu, J. H.; Wu, G. H.; Chen, Y. Z. Inhibitory effect of curcumin on proliferation of K562 cells involves down-regulation of p210(bcr/abl) initiated Ras signal transduction pathway Acta Pharmacol. Sin. 2003, 24, 1155-1160
19. Mohanty, C.; Acharya, S.; Mohanty, A. K.; Dilnawaz, F.; Sahoo, S. K. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy Nanomedicine (London) 2010, 5, 433-449
20. Mohanty, C.; Sahoo, S. K. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation Biomaterials 2010, 31, 6597-6611
21. Jakubowska, J.; Stasiak, M.; Szulawska, A.; Bednarek, A.; Czyz, M. Combined effects of doxorubicin and STI571 on growth, differentiation and apoptosis of CML cell line K562 Acta Biochim. Pol. 2007, 54, 839-846
22. Mayer, L. D.; Janoff, A. S. Optimizing combination chemotherapy by controlling drug ratios Mol. Interventions 2007, 7, 216-223 (Pubitemid 47437268)
23. Lammers, T.; Subr, V.; Ulbrich, K.; Peschke, P.; Huber, P. E.; Hennink, W. E.; Storm, G. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers Biomaterials 2009, 30, 3466-3475
24. Sengupta, S.; Eavarone, D.; Capila, I.; Zhao, G.; Watson, N.; Kiziltepe, T.; Sasisekharan, R. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system Nature 2005, 436, 568-572 (Pubitemid 41112931)
25. Indap, M. A.; Radhika, S.; Motiwale, L.; Rao, K. V. Inhibitory effect of cinnamoyl compounds against human malignant cell line Indian J. Exp. Biol. 2006, 44, 216-220 (Pubitemid 43351245)
26. Kelkel, M.; Jacob, C.; Dicato, M.; Diederich, M. Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies Molecules 2010, 15 (10) 7035-7074
27. Choi, B. H.; Kim, C. G.; Lim, Y.; Shin, S. Y.; Lee, Y. H. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway Cancer Lett. 2008, 259, 111-118 (Pubitemid 350235095)
28. Das, M.; Sahoo, S. K. Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy. Acta Biomater. 2010, 7, 355 - 369
29. Misra, R.; Sahoo, S. K. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy Eur. J. Pharm. Sci. 2010, 39, 152-163
30. Sahoo, S. K.; Ma, W.; Labhasetwar, V. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer Int. J. Cancer 2004, 112, 335-340 (Pubitemid 39244375)
31. Shaikh, J.; Ankola, D. D.; Beniwal, V.; Singh, D.; Kumar, M. N. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer Eur. J. Pharm. Sci. 2009, 37, 223-230
32. Acharya, S.; Dilnawaz, F.; Sahoo, S. K. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy Biomaterials 2009, 30, 5737-5750
33. Chen, B.; Liang, Y.; Wu, W.; Cheng, J.; Xia, G.; Gao, F.; Ding, J.; Gao, C.; Shao, Z.; Li, G.; Chen, W.; Xu, W.; Sun, X.; Liu, L.; Li, X.; Wang, X. Synergistic effect of magnetic nanoparticles of Fe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cells Int. J. Nanomed. 2009, 4, 251-259
34. Dilnawaz, F.; Singh, A.; Mohanty, C.; Sahoo, S. K. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy Biomaterials 2010, 31, 3694-3706
35. Misra, R.; Acharya, S.; Dilnawaz, F.; Sahoo, S. K. Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles Nanomedicine (London) 2009, 4, 519-530
36. Vandana, M.; Sahoo, S. K. Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer Biomaterials 2010, 31, 9340-9356
37. Fang, G.; Kim, C. N.; Perkins, C. L.; Ramadevi, N.; Winton, E.; Wittmann, S.; Bhalla, K. N. CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs Blood 2000, 96, 2246-2253
38. Sanchez, Y.; Simon, G. P.; Calvino, E.; de Blas, E.; Aller, P. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines J. Pharmacol. Exp. Ther. 2010, 335, 114-123
39. Toffoli, G.; Viel, A.; Bevilacqua, C.; Maestro, R.; Tumiotto, L.; Boiocchi, M. In K562 leukemia cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation Leuk. Res. 1989, 13, 279-287 (Pubitemid 19105680)
40. Gao, M.; Fan, S.; Goldberg, I. D.; Laterra, J.; Kitsis, R. N.; Rosen, E. M. Hepatocyte growth factor/scatter factor blocks the mitochondrial pathway of apoptosis signaling in breast cancer cells J. Biol. Chem. 2001, 276, 47257-47265
41. Jakubowska, J.; Wasowska-Lukawska, M.; Czyz, M. STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis Eur. J. Pharmacol. 2008, 596, 41-49
42. Cilloni, D.; Saglio, G. CML: a model for targeted therapy Best Pract. Res. Clin. Haematol. 2009, 22, 285-294
43. Salesse, S.; Verfaillie, C. M. BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia Oncogene 2002, 21, 8547-8559 (Pubitemid 36084187)
44. Gong, Y.; Duvvuri, M.; Krise, J. P. Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resistant human leukemic cell line HL-60 J. Biol. Chem. 2003, 278, 50234-50239 (Pubitemid 37548864)
45. Noskova, V.; Dzubak, P.; Kuzmina, G.; Ludkova, A.; Stehlik, D.; Trojanec, R.; Janostakova, A.; Korinkova, G.; Mihal, V.; Hajduch, M. In vitro chemoresistance profile and expression/function of MDR associated proteins in resistant cell lines derived from CCRF-CEM, K562, A549 and MDA MB 231 parental cells Neoplasma 2002, 49, 418-425 (Pubitemid 36139245)
46. Bedi, A.; Barber, J. P.; Bedi, G. C.; el-Deiry, W. S.; Sidransky, D.; Vala, M. S.; Akhtar, A. J.; Hilton, J.; Jones, R. J. BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents Blood 1995, 86, 1148-1158
47. Hochhaus, A.; Reiter, A.; Skladny, H.; Melo, J. V.; Sick, C.; Berger, U.; Guo, J. Q.; Arlinghaus, R. B.; Hehlmann, R.; Goldman, J. M.; Cross, N. C. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia Blood 1996, 88, 2236-2240 (Pubitemid 26307927)
48. Prasad, S.; Phromnoi, K.; Yadav, V. R.; Chaturvedi, M. M.; Aggarwal, B. B. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer Planta Med. 2010, 76, 1044-1063
49. Park, J.; Ayyappan, V.; Bae, E. K.; Lee, C.; Kim, B. S.; Kim, B. K.; Lee, Y. Y.; Ahn, K. S.; Yoon, S. S. Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells Mol. Oncol. 2008, 2, 317-326
50. Sahoo, S. K.; Labhasetwar, V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention Mol. Pharmaceutics 2005, 2, 373-383 (Pubitemid 41503678)
51. Ferrao, P.; Sincock, P.; Cole, S.; Ashman, L. Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia Leuk. Res. 2001, 25, 395-405 (Pubitemid 32294284)